Get started
Author

Viktor Dahl

Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
2013 · Susanne Eriksson, Erin H. Graf, et al. · PLoS Pathogens · 583
PDF
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
2010 · Maria J Buzón, Marta Massanella, et al. · Nature Medicine · 562
A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
2011 · Hiroyu Hatano, Timothy L. Hayes, et al. · The Journal of Infectious Diseases · 203
Chlamydia trachomatis infection and persistence of human papillomavirus
2005 · Ilvars Silins, Walter Ryd, et al. · International Journal of Cancer · 170
PDF
Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation
2014 · Viktor Dahl, Julia Peterson, et al. · AIDS · 151
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
2013 · Peter W. Hunt, Nancy S. Shulman, et al. · Blood · 141
Treatment Intensification with Raltegravir in Subjects with Sustained HIV-1 Viraemia Suppression: A Randomized 48-Week Study
2011 · Josep M Llibre, Maria J Buzón, et al. · Antiviral Therapy · 128
HIV reservoirs, latency, and reactivation: Prospects for eradication
2009 · Viktor Dahl, Lina Josefsson, et al. · Antiviral Research · 124
Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected
2011 · Carolina Gutiérrez, Laura Díaz, et al. · PLoS ONE · 97
PDF
Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
2011 · Viktor Dahl, Evelyn Lee, et al. · The Journal of Infectious Diseases · 70
PDF
Acceptance of HIV testing among women attending antenatal care in south-western Uganda: risk factors and reasons for test refusal
2008 · V. Dahl, L. Mellhammar, et al. · AIDS Care · 68
An Example of Genetically Distinct HIV Type 1 Variants in Cerebrospinal Fluid and Plasma During Suppressive Therapy
2013 · Viktor Dahl, Magnus Gisslen, et al. · The Journal of Infectious Diseases · 52
PDF
Lyme neuroborreliosis epidemiology in Sweden 2010 to 2014: clinical microbiology laboratories are a better data source than the hospital discharge diagnosis register
2019 · Viktor Dahl, Karin T Wisell, et al. · Eurosurveillance · 35
PDF
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers
2012 · Viktor Dahl, Julia Peterson, et al. · AIDS · 24
Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013
2015 · Viktor Dahl, Anders Tegnell, et al. · PLoS ONE · 23
PDF
Can HIV infection be eradicated through use of potent antiviral agents?
2010 · Lina Josefsson, Viktor Dahl, et al. · Current Opinion in Infectious Diseases · 22
Multi-country outbreak ofSalmonella enteritidisinfection linked to the international ice hockey tournament
2017 · T. PÄRN, V. DAHL, et al. · Epidemiology and Infection · 19
PDF
Establishment of Drug‐Resistant HIV‐1 in Latent Reservoirs
2009 · Viktor Dahl, Sarah Palmer · The Journal of Infectious Diseases · 16
Self-reported infections during international travel and notifiable infections among returning international travellers, Sweden, 2009-2013
2017 · Viktor Dahl, Anders Wallensten · PLoS ONE · 14
PDF
A nationwide outbreak of listeriosis associated with cold-cuts, Sweden 2013-2014
2017 · Viktor Dahl, Lena Sundqvist, et al. · Infection Ecology & Epidemiology · 13
Searching for unknown transfusion‐transmitted hepatitis viruses: a binational cohort study of 1.5 million transfused patients
2018 · G. Edgren, H. Hjalgrim, et al. · Journal of Internal Medicine · 9
PDF
Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012
2020 · Viktor Dahl, Ammar Majeed, et al. · Eurosurveillance · 8
PDF
Monitoring the progress towards the elimination of hepatitis B and C in Sweden: estimation of core indicators for 2015 and 2018
2022 · Soledad Colombe, Maria Axelsson, et al. · BMC Infectious Diseases · 7
PDF
Difficult-to-treat HIV in Sweden: a cross-sectional study
2024 · Olof Elvstam, Viktor Dahl, et al. · BMC Infectious Diseases · 1
PDF
Correction: Communicable Diseases Prioritized According to Their Public Health Relevance, Sweden, 2013
2017 · Viktor Dahl, Anders Tegnell, et al. · PLoS ONE · 1
PDF
Works count: 26
Citation count: 2,542
H-index: 17
I10-index: 20
Year
Topic
Type